PRESS RELEASE published on 09/27/2023 at 21:49, 1 year 1 month ago SCHOTT Pharma IPO: Final offer price set at EUR 27.00 per share
PRESS RELEASE published on 09/27/2023 at 21:39, 1 year 1 month ago EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: Final offer price for shares in SCHOTT Pharma set at EUR 27.00 per share
PRESS RELEASE published on 09/18/2023 at 07:26, 1 year 2 months ago SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma shares to be offered within price range of EUR 24.50 to EUR 28.50 per share
PRESS RELEASE published on 09/06/2023 at 07:21, 1 year 2 months ago SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma plans Initial Public Offering
PRESS RELEASE published on 06/22/2023 at 07:33, 1 year 5 months ago SCHOTT Pharma AG & Co. KGaA: Upholding momentum: SCHOTT Pharma sustains strong growth in the first half of FY 2023
PRESS RELEASE published on 01/26/2023 at 09:37, 1 year 9 months ago SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma with strong financial performance in fiscal year 2022
Published on 11/22/2024 at 23:55, 9 hours 18 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 9 hours 43 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 10 hours 8 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 10 hours 43 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 14 hours 59 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 15 hours 20 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 16 hours 18 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 17 hours 13 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 2 days 2 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 13 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 15 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 15 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
